Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging

Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S. Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A. Sebag; Deborah A. Agler; Luigi P. Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M. Decara; Thor Edvardsen; Scott D. Flamm; Thomas Force; Brian P. Griffin; Guy Jerusalem; Jennifer E. Liu; Andreia Magalhães; Thomas Marwick; Liza Y. Sanchez; Rosa Sicari; Hector R. Villarraga; Patrizio Lancellotti

doi:10.1016/j.echo.2014.07.012

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging

Juan Carlos Plana, Maurizio Galderisi, Ana Barac, Michael S. Ewer, Bonnie Ky, Marielle Scherrer-Crosbie, Javier Ganame, Igal A. Sebag, Deborah A. Agler, Luigi P. Badano, Jose Banchs, Daniela Cardinale, Joseph Carver, Manuel Cerqueira, Jeanne M. Decara, Thor Edvardsen, Scott D. Flamm, Thomas Force, Brian P. Griffin, Guy JerusalemJennifer E. Liu, Andreia Magalhães, Thomas Marwick, Liza Y. Sanchez, Rosa Sicari, Hector R. Villarraga, Patrizio Lancellotti

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

611 Scopus citations

Original language	English (US)
Pages (from-to)	911-939
Number of pages	29
Journal	Journal of the American Society of Echocardiography
Volume	27
Issue number	9
DOIs	https://doi.org/10.1016/j.echo.2014.07.012
State	Published - Sep 2014

Keywords

Biomarkers
Chemotherapy
Doxorubicin
Early detection
Left ventricular dysfunction
Strain
Three-dimensional echocardiography
Trastuzumab

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.echo.2014.07.012

Cite this

Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., Banchs, J., Cardinale, D., Carver, J., Cerqueira, M., Decara, J. M., Edvardsen, T., Flamm, S. D., Force, T., Griffin, B. P., ... Lancellotti, P. (2014). Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging. Journal of the American Society of Echocardiography, 27(9), 911-939. https://doi.org/10.1016/j.echo.2014.07.012

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy : A report from the American society of echocardiography and the European association of cardiovascular imaging. / Plana, Juan Carlos; Galderisi, Maurizio; Barac, Ana et al.

In: Journal of the American Society of Echocardiography, Vol. 27, No. 9, 09.2014, p. 911-939.

Research output: Contribution to journal › Article › peer-review

Plana, JC, Galderisi, M, Barac, A, Ewer, MS, Ky, B, Scherrer-Crosbie, M, Ganame, J, Sebag, IA, Agler, DA, Badano, LP, Banchs, J, Cardinale, D, Carver, J, Cerqueira, M, Decara, JM, Edvardsen, T, Flamm, SD, Force, T, Griffin, BP, Jerusalem, G, Liu, JE, Magalhães, A, Marwick, T, Sanchez, LY, Sicari, R, Villarraga, HR & Lancellotti, P 2014, 'Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging', Journal of the American Society of Echocardiography, vol. 27, no. 9, pp. 911-939. https://doi.org/10.1016/j.echo.2014.07.012

Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging. Journal of the American Society of Echocardiography. 2014 Sep;27(9):911-939. doi: 10.1016/j.echo.2014.07.012

Plana, Juan Carlos ; Galderisi, Maurizio ; Barac, Ana et al. / Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy : A report from the American society of echocardiography and the European association of cardiovascular imaging. In: Journal of the American Society of Echocardiography. 2014 ; Vol. 27, No. 9. pp. 911-939.

@article{2f790a7be8e84f63a6692f5c6515bc1e,

title = "Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging",

keywords = "Biomarkers, Chemotherapy, Doxorubicin, Early detection, Left ventricular dysfunction, Strain, Three-dimensional echocardiography, Trastuzumab",

author = "Plana, {Juan Carlos} and Maurizio Galderisi and Ana Barac and Ewer, {Michael S.} and Bonnie Ky and Marielle Scherrer-Crosbie and Javier Ganame and Sebag, {Igal A.} and Agler, {Deborah A.} and Badano, {Luigi P.} and Jose Banchs and Daniela Cardinale and Joseph Carver and Manuel Cerqueira and Decara, {Jeanne M.} and Thor Edvardsen and Flamm, {Scott D.} and Thomas Force and Griffin, {Brian P.} and Guy Jerusalem and Liu, {Jennifer E.} and Andreia Magalh{\~a}es and Thomas Marwick and Sanchez, {Liza Y.} and Rosa Sicari and Villarraga, {Hector R.} and Patrizio Lancellotti",

note = "Funding Information: The following authors reported no actual or potential conflicts of interest in relation to this document: Juan Carlos Plana, MD, FASE, Maurizio Galderisi, MD, FESC, Marielle Scherrer-Crosbie, MD, PhD, FASE, Javier Ganame, MD, PhD, FASE, Deborah A. Agler, RCT, RDCS, FASE, Luigi P. Badano, MD, PhD, FESC, Jose Banchs, MD, FASE, Daniela Cardinale, MD, Joseph Carver, MD, Thor Edvardsen, MD, PhD, FESC, Brian Griffin, MD, Guy Jerusalem, MD, PhD, Jennifer E. Liu, MD, FASE, Andreia Magalh{\~a}es, MD, Liza Y. Sanchez, RCS, FASE, Rosa Sicari, MD, PhD, FESC, Hector R. Villarraga, MD, FASE, and Patrizio Lancellotti, MD, PhD, FESC. The following authors reported relationships with one or more commercial interests: Ana Barac, MD, received research funding and lectures honoraria from Genentech and consultancy fees from Cell Therapeutics . Manuel Cerqueira, MD, received a grant from Perceptive Informatics, Inc ; consults for GE Healthcare, FluoroPharma and Astellas; and serves on the speakers bureau for Astellas. Jeanne M. DeCara, MD, served as a consultant for Epsilon Imaging and Methylgene. Michael S. Ewer, MD, JD, consults or serves as advisory board member for Roche Laboratories, Cell Therapeutics, GlaxoSmithKline, and Boehringer Ingelheim. Scott D. Flamm, MD, MBA, serves on advisory boards for Philips Healthcare, Bayer Healthcare, and TeraRecon and received institutional research support from Siemens Healthcare . Thomas Force, MD consults for GlaxoSmithKline. Bonnie Ky, MD, FASE, received an investigator-initiated award from Pfizer, Inc . Thomas Marwick, MBBS, PhD, MPH, received research funding from the National Health and Medical Research Council in Australia and the Royal Hobart Hospital Foundation , an equipment grant from Philips Medical Systems and Siemens , and a project grant from GE Medical Systems . Igal A. Sebag, MD, FASE, serves on the speakers bureau for Lantheus. ",

year = "2014",

month = sep,

doi = "10.1016/j.echo.2014.07.012",

language = "English (US)",

volume = "27",

pages = "911--939",

journal = "Journal of the American Society of Echocardiography",

issn = "0894-7317",

publisher = "Mosby Inc.",

number = "9",

}

TY - JOUR

T1 - Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy

T2 - A report from the American society of echocardiography and the European association of cardiovascular imaging

AU - Plana, Juan Carlos

AU - Galderisi, Maurizio

AU - Barac, Ana

AU - Ewer, Michael S.

AU - Ky, Bonnie

AU - Scherrer-Crosbie, Marielle

AU - Ganame, Javier

AU - Sebag, Igal A.

AU - Agler, Deborah A.

AU - Badano, Luigi P.

AU - Banchs, Jose

AU - Cardinale, Daniela

AU - Carver, Joseph

AU - Cerqueira, Manuel

AU - Decara, Jeanne M.

AU - Edvardsen, Thor

AU - Flamm, Scott D.

AU - Force, Thomas

AU - Griffin, Brian P.

AU - Jerusalem, Guy

AU - Liu, Jennifer E.

AU - Magalhães, Andreia

AU - Marwick, Thomas

AU - Sanchez, Liza Y.

AU - Sicari, Rosa

AU - Villarraga, Hector R.

AU - Lancellotti, Patrizio

N1 - Funding Information: The following authors reported no actual or potential conflicts of interest in relation to this document: Juan Carlos Plana, MD, FASE, Maurizio Galderisi, MD, FESC, Marielle Scherrer-Crosbie, MD, PhD, FASE, Javier Ganame, MD, PhD, FASE, Deborah A. Agler, RCT, RDCS, FASE, Luigi P. Badano, MD, PhD, FESC, Jose Banchs, MD, FASE, Daniela Cardinale, MD, Joseph Carver, MD, Thor Edvardsen, MD, PhD, FESC, Brian Griffin, MD, Guy Jerusalem, MD, PhD, Jennifer E. Liu, MD, FASE, Andreia Magalhães, MD, Liza Y. Sanchez, RCS, FASE, Rosa Sicari, MD, PhD, FESC, Hector R. Villarraga, MD, FASE, and Patrizio Lancellotti, MD, PhD, FESC. The following authors reported relationships with one or more commercial interests: Ana Barac, MD, received research funding and lectures honoraria from Genentech and consultancy fees from Cell Therapeutics . Manuel Cerqueira, MD, received a grant from Perceptive Informatics, Inc ; consults for GE Healthcare, FluoroPharma and Astellas; and serves on the speakers bureau for Astellas. Jeanne M. DeCara, MD, served as a consultant for Epsilon Imaging and Methylgene. Michael S. Ewer, MD, JD, consults or serves as advisory board member for Roche Laboratories, Cell Therapeutics, GlaxoSmithKline, and Boehringer Ingelheim. Scott D. Flamm, MD, MBA, serves on advisory boards for Philips Healthcare, Bayer Healthcare, and TeraRecon and received institutional research support from Siemens Healthcare . Thomas Force, MD consults for GlaxoSmithKline. Bonnie Ky, MD, FASE, received an investigator-initiated award from Pfizer, Inc . Thomas Marwick, MBBS, PhD, MPH, received research funding from the National Health and Medical Research Council in Australia and the Royal Hobart Hospital Foundation , an equipment grant from Philips Medical Systems and Siemens , and a project grant from GE Medical Systems . Igal A. Sebag, MD, FASE, serves on the speakers bureau for Lantheus.

PY - 2014/9

Y1 - 2014/9

KW - Biomarkers

KW - Chemotherapy

KW - Doxorubicin

KW - Early detection

KW - Left ventricular dysfunction

KW - Strain

KW - Three-dimensional echocardiography

KW - Trastuzumab

UR - http://www.scopus.com/inward/record.url?scp=84906834548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906834548&partnerID=8YFLogxK

U2 - 10.1016/j.echo.2014.07.012

DO - 10.1016/j.echo.2014.07.012

M3 - Article

C2 - 25172399

AN - SCOPUS:84906834548

SN - 0894-7317

VL - 27

SP - 911

EP - 939

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

IS - 9

ER -

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this